Chongqing Zhifei Biological Products Co., Ltd.
300122
Rang in Aktien
#3837
Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily... Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily engaged in the innovation, manufacturing, and commercialization of vaccines and other biological pharmaceuticals within the country. The company's establishment dates back to 2009, and its main operational base is located in Chongqing, China.
Aktienkurs
$1.81
Zuletzt synchronisiert: 2026-10-20
Marktkapitalisierung
$4.34B
Veränderung (1 Tag)
0.16%
Veränderung (1 Jahr)
-36.29%
Land
CN
Handel Chongqing Zhifei Biological Products Co., Ltd. (300122)
Kategorie
Healthcare
Dividendenrendite-Verlauf für Chongqing Zhifei Biological Products Co., Ltd. (300122)
Dividendenrendite (TTM) von Chongqing Zhifei Biological Products Co., Ltd. (Aktienkürzel: 300122) zum 2023-12-31: 0.62%
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 1.28%
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 1.28%
Dividendenrendite-Verlauf für Chongqing Zhifei Biological Products Co., Ltd. (300122) von 2007 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
| Jahr | Dividendenrendite | ändert |
|---|---|---|
| 2026 (TTM) | 0.00% | -100.00% |
| 2024 | 4.01% | 546.77% |
| 2023 | 0.62% | -8.82% |
| 2022 | 0.68% | 13.33% |
| 2021 | 0.60% | 17.65% |
| 2020 | 0.51% | -66.23% |
| 2019 | 1.51% | 147.54% |
| 2018 | 0.61% | 662.50% |
| 2017 | 0.08% | -82.98% |
| 2016 | 0.47% | 11.90% |
| 2015 | 0.42% | -44.00% |
| 2014 | 0.75% | -12.79% |
| 2013 | 0.86% | -14.85% |
| 2012 | 1.01% | 0.00% |
| 2011 | 1.01% | 0.00% |
| 2010 | 0.00% | -100.00% |
| 2009 | 0.33% | -44.07% |
| 2008 | 0.59% | 883.33% |
| 2007 | 0.06% | 0.00% |
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | Dividendenrendite | Land |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
